Generation of a New Humanized Pompe Disease Model for Improved Robust // Pre-Clinical Evaluation of new Pompe Therapeutics
The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms.Autores: E Silva-Saffar S, Mariette X, Gottenberg JE, Bombardieri M, Cornec D, Alarcon-Riquelme ME, PRECISEADS consortium, Barnes MR, Ng S, Ng WF, Nocturne G, Niarakis A03/2026 - NPJ systems biology and applications
Validation of ITPR2, DPF3, EPAS1, and PVT1-associated SNPs as biomarkers for RCC in an independent case-control cohort.Autores: Morales-Álvarez CM, Jiménez-Domínguez AC, Rios-Pelegrina RM, Arance E, Marín-Benesiu F, Vázquez-Alonso F, Martínez-González LJ, Álvarez-Cubero MJ03/2026 - Frontiers in medicine
Circulating levels of insulin-like growth factor I (IGF-I) and risk of multiple myeloma: An observational and Mendelian randomisation study.Autores: Benavente Y, Hermosa S, Papadimitriou N, Clay-Gilmour A, Brown EE, Hofmann JN, Rothman N, Lan Q, Berndt SI, Albanes D, Purdue M, Machiela MJ, Chanock SJ, Bhatti P, Cozen W, Norman A, Slager SL, Cerhan JR, Rajkumar V, Kumar SK, Vachon CM, Novak AJ, Habermann TM, Link BK, Salles G, Ghesquieres H, Bracci PM, Holly E, Griffin RG, Hildebrandt MAT, Vermeulen RCH, Kolijn PM, Hjalgrim H, Smedby KE, Jayasekara H, Cheah S, Monnereau A, Chen Y, Arslan A, Zhang Y, Camp NJ, Sborov DW, Osman AEG, Ziv E, De Vivo I, Joseph V, Teras LR, Patel AV, Kane E, Vajdic CM, Guilloteau A, Cocco P, Alemany L, Sainz J, McKay J, Birmann BM, Casabonne D03/2026 - British journal of haematology
